Abstract:Objectives: To develop and validate an index predictive of adverse perinatal outcome (APO) in pregnancies meeting the consensus-based criteria for fetal growth restriction (FGR) endorsed by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Methods: This was a retrospective analysis of consecutive singleton non-anomalous gestations meeting the ISUOG-endorsed criteria for FGR at a single tertiary care center from November 2010 to August 2020. The dataset was divided randomly into a development set (two-thirds) and a validation set (one-third). The primary composite APO comprised one or more of: perinatal demise, Grade III-IV intraventricular hemorrhage (IVH), periventricular leukomalacia (PVL), seizures, hypoxic ischemic encephalopathy (HIE), necrotizing enterocolitis (NEC), sepsis, bronchopulmonary dysplasia (BPD) and length of stay in the neonatal intensive care unit (NICU) > 7 days. Regression analysis incorporated clinical factors readily available at the time of FGR diagnosis. The sum of β coefficient-based weights yielded an index score, the performance of which was assessed in the validation set. Score cut-offs were selected to identify 'high-risk' and 'low-risk' ranges for which positive (PPV) and negative (NPV) predictive values and positive (LR+) and negative (LR-) likelihood ratios were calculated. Results: Of the 875 consecutive pregnancies that met the criteria for FGR and were included in the study cohort, 405 (46%) were complicated by one or more components of the composite APO, including 54 (6%) perinatal deaths, 22 (3%) neonates with Grade III-IV IVH and/or PVL, nine (1%) with seizures and/or HIE, 91 (10%) with BPD, 57 (7%) with sepsis, 21 (2%) with NEC, and 361 (41%) who remained in the NICU > 7 days. In addition, 270 (31%) pregnancies were delivered by Cesarean section for non-reassuring fetal status, 43 (5%) were admitted to the NICU for < 7 days, 79 (9%) had 5-min Apgar score < 7, 125/631 (20%) had a cord gas pH ≤ 7.1 and 35/631 (6%) had a base excess ≥ 12 mmol/L. The predictive index we developed included seven factors available at the time of FGR diagnosis: hypertensive disorder of pregnancy (HDP) (+8 points), chronic hypertension without HDP (+4 points), gestational age ≤ 32 weeks (+5 points), absent or reversed end-diastolic flow in the umbilical artery (+8 points), prepregnancy body mass index ≥ 35 kg/m2 (+3 points), isolated abdominal circumference < 3rd percentile (-4 points) and non-Hispanic black race (-2 points). The bias-corrected bootstrapped (1000 replicates) area under the receiver-operating-characteristics curve (AUC) of the predictive index for composite APO in the validation group was 0.88 (95% CI, 0.84-0.92), which was similar to that in the development group (AUC, 0.86 (95% CI, 0.82-0.89); P = 0.34). In the total cohort, 40% of pregnancies had a low-risk index score (≤ 2), associated with a NPV of 85% (95% CI, 81-88%) and a LR- of 0.21 (95% CI, 0.16-0.27), and 23% had a high-risk index score (≥ 10), associated with a PPV of 96% (95% CI, 93-98%) and a LR+ of 27.36 (95% CI, 14.33-52.23). Of the remaining pregnancies that had an intermediate-risk score, 50% were complicated by composite APO. Conclusion: An easy-to-use index incorporating seven clinical factors readily available at the time of FGR diagnosis is predictive of APO and may prove useful in counseling and management of pregnancies meeting the ISUOG-endorsed criteria for FGR. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

Clinical value of prenatal screening markers in early pregnancy combined with perinatal characteristics to predict fetal growth restriction

Clinical value of S/D ratio of umbilical arteries and Z-scores of multiple ultrasound parameters in evaluating fetal growth restriction in pregnant women with gestational diabetes mellitus

Predictive Significance of Risk Value in Prenatal Screening for Fetal Trisomy 18

First-trimester Screening for Fetal Growth Restriction Using Doppler Color Flow Analysis of the Uterine Artery and Serum PAPP-A Levels in Unselected Pregnancies

Risk evaluation of fetal growth restriction by combined screening in early and mid-pregnancy

Combined prevention of fetal growth restriction based on determination of diagnostic markers

Associations between first-trimester screening biomarkers and maternal characteristics with gestational diabetes mellitus in Chinese women

The Application Value of Three-Dimensional Power Doppler Ultrasound in Fetal Growth Restriction

First Trimester Maternal Serum Analytes and Second Trimester Uterine Artery Doppler in the Prediction of Preeclampsia and Fetal Growth Restriction.

First-Trimester Screening's Role in Identifying Neonatal Complications

Clinical Characteristics and Pregnancy Outcomes of Preeclampsia Complicated with Fetal Growth Restriction

The Genetic and Clinical Outcomes in Fetuses With Isolated Fetal Growth Restriction: A Chinese Single-Center Retrospective Study

Evaluation of the value of fasting plasma glucose in the first trimester for the prediction of adverse pregnancy outcomes

A Nomogram for Predicting Adverse Perinatal Outcome in Patients with Fetal Growth Restriction: A Prospective Observational Study

Clinical Comparative Analysis of Fetal Growth Restriction With/without Maternal Complications

Diagnosis of fetal chromosomal aneuploidy by free fetal DNA in maternal plasma in the first trimester

New Predictive Model at 11+0 to 13+6 Gestational Weeks for Early-Onset Preeclampsia with Fetal Growth Restriction

Predictive index for adverse perinatal outcome in pregnancies complicated by fetal growth restriction

Fetal genetic findings by chromosomal microarray analysis and karyotyping for fetal growth restriction without structural malformations at a territory referral center: 10-year experience

An Externally Validated Normogram for Predicting Short-Term Pregnancy Outcome of Singleton Pregnancies with Fetal Growth Restriction (FGR)

Metabolic Dynamics and Prediction of Sfgr and Adverse Fetal Outcomes: a Prospective Longitudinal Cohort Study.